Omada Health, Inc. (OMDA)

Omada Health, Inc. is a virtual healthcare company headquartered in San Francisco that provides programs for people living with chronic conditions. Its services combine connected devices such as cellular scales and glucose meters, a mobile app, and support from health coaches and clinical specialists.

Omada's programs address prediabetes, type 2 diabetes, hypertension and musculoskeletal pain, and it offers support for members taking GLP-1 medications. The company sells mainly to employers, health plans, pharmacy benefit managers and other payers, which provide the programs to their members, and it is often paid based on member enrollment and outcomes.

Founded in 2011, Omada completed its initial public offering in 2025, and its common stock trades on the Nasdaq.